EMGALITY (GALCANEZUMAB-GNLM) — FDA Approval BLA761063 (ELI LILLY AND CO)
EMGALITY (GALCANEZUMAB-GNLM) — FDA Approval BLA761063 (ELI LILLY AND CO) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: EMGALITY; Active ingredients: GALCANEZUMAB-GNLM; Application number: BLA761063.
| Brand name | EMGALITY |
|---|---|
| Active ingredients | GALCANEZUMAB-GNLM |
| Application number | BLA761063 |
| Sponsor | ELI LILLY AND CO |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20180927 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →